Category: Technology Licenses
Created On: 2022-04-28
Record Count: 8
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 27723
IPSCIO Record ID: 1850
(v) Epidural catheters used to infuse drugs into the epidural space in the spinal column.
(vi) Implantable infusion ports and pumps and their attached catheters used for drug therapy and access to the vascular system.
(vii) Intra-aortic balloon catheters.
(viii) Drainage catheters used to drain chest cavities, surgical incisions, wounds and abscesses.
IPSCIO Record ID: 28439
IPSCIO Record ID: 266858
Licensor has licensed certain rights to Active Agents as locally delivered therapeutics in the Field with rights to sublicense to Licensee pursuant to an Amended and Restated Agreement between Institut National de la Sante et de la Recherche Medicate and Licensor.
Licensor owns or has rights to certain proprietary technology for site-specific and time-released delivery of drugs, defined as the Licensor Drug Delivery Platforms.
Gacyclidine shall mean cis-1-(2-thienyl)-1-N-piperidinyl-2-methycyclohexane hydrochloride in its racemic form.
Licensed Product shall mean any pharmaceutical formulation containing an Active Agent or, a product incorporating an active ingredient and a Licensor Drug Delivery Platform pursuant to Licensee opting to develop such Licensed Product, in any case for use in the Field.
Licensor Drug Delivery Platforms shall mean the following drug delivery technology or methods owned or Controlled by Licensor the DUROS Technology Platform, the SABER Delivery System, the DORIN Biodegradable Implant Technology, the MICRODUR Biodegradable Microparticle Technology, and any other drug delivery technology owned or Controlled by Licensor as of the Effective Date.
The Intellectual Property is to market and sell products for the treatment of certain inner ear disorders including chronic tinnitus (ringing in the ears). Over eight million people in the U.S. suffer from chronic ringing, hissing, buzzing or other noises in one or both ears, a condition known as tinnitus.
IPSCIO Record ID: 268269
IPSCIO Record ID: 2991
IPSCIO Record ID: 164315
Licensor grants the Licensee a non-exclusive license, or, if applicable, sublicense, to use the Licensors Trademarks, upon or in relation to the promotion, marketing, advertising, sale or offering for sale of the Licensors Royalty Products.
The Licensors Medipad System Patent Portfolio includes, among others, patents and applications for Method and Device for Entrapping a Volume of Gas in a Liquid Drug Container, Improved Method of Packaging a Drug Delivery Kit, Cartridge-Based Drug Delivery Device and Medicament Delivery Device.
Medipad/TM/ is a lightweight, disposable drug delivery system, which combines the simplicity of a patch with the extensive delivery capabilities of an infusion pump.
IPSCIO Record ID: 26795